Increasing Efficiency and Impact
The Innovation Working Group (IWG) was created in 2010 to tap into the potential of innovations that can accelerate progress towards the health MDGs, in support of the Global Strategy for Women’s and Children’s Health.
The IWG members work with the knowledge that innovation can enable further progress toward the reduction of maternal and child health. Through catalytic partnerships, four taskforces of the IWG (on checklists, medical devices, sustainable business models and innovative financing) have worked on developing examples of innovations in their respective fields that can help further this progress. The IWG continues working to find innovative ways to deliver enabling environments and solutions which can be brought up to scale based on the examples and pilots that worked, for a real impact on women’s and children’s health.
The IWG is co-chaired by the government of Norway and GlaxoSmithKline (GSK).
Without Innovation, hundreds of thousands of women and girls will continue to die in pregnancy and childbirth each year, and between 10 and 15 million more will suffer long-lasting disabilities.
Tore Godal, Special Adviser on Global Health to the Norwegian Ministry of foreign Affairs.
Allan Pamba, Vice President Pharmaceuticals, East Africa and Government Affairs, Africa, at GSK.
Haitham El-noush, Senior Adviser, Norwegian Agency for for Development Cooperation (NORAD)